In this CrownCast episode, host Michelle Dawn Mooney speaks with Graham Marsh, Director of the NAMs Developer Coalition at the Critical Path Institute, and Ludovic Bourré, Vice President of Research and Innovation at Crown Bioscience, to explore new approach methodologies (NAMs) and Crown Bioscience’s participation in the coalition. Together, they discuss how patient-derived models, organoids, ex vivo tissue platforms, translational biomarkers, and bioinformatics contribute to the field, and what validation, qualification, and regulatory adoption could mean for practical study design.
More episodes from "CrownCast"



Don't miss an episode of “CrownCast” and subscribe to it in the GetPodcast app.








